SPY
774.46
+0.07%
QQQ
747.75
+0.02%
BTC/USD
82,177.55
+0.59%
DIA
511.79
+0.03%
GLD
379.46
+0.22%
TLT
77.66
−0.27%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Solana Co
HSDT
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$2.38
-0.16
-6.3%
Last update: Oct 8, 7:58 PM
$2.41
-0.13
-5.12%
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Ownership
Compare
Options
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Solana Financials
Solana (HSDT) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Helius Medical Tech Q2 EPS $(0.38) Misses $(0.07) Estimate, Sales $2.526M Miss $3.600M Estimate
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.07) by 442.86 percent. This is a 99.52 percent increase over losses of $(79.73) per
Benzinga Newsdesk
PRO
Helius Medical Tech Q1 EPS $(1.30) Misses $(0.48) Estimate, Sales $3.620M Beat $3.400M Estimate
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.30) per share which missed the analyst consensus estimate of $(0.48) by 170.83 percent. This is a 99.66 percent increase over losses of $(382.50) per
Benzinga Newsdesk
Earnings Scheduled For May 15, 2026
Benzinga Insights
PRO
Helius Medical Tech Q4 EPS $4.25, Sales $5.228M
Benzinga Newsdesk
Earnings Scheduled For March 30, 2026
Benzinga Insights
PRO
Helius Medical Tech Q3 EPS $(32.89) Beats $(50.50) Estimate, Sales $697.000K Beat $110.000K Estimate
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(32.89) per share which beat the analyst consensus estimate of $(50.50) by 34.87 percent. This is a 95.57 percent increase over losses of $(742.50) per
Benzinga Newsdesk
